Global Vial Adaptors for Reconstitution Drug Market: Snapshot
The global market for vial adaptors for reconstitution drugs has been experiencing a steady demand as these vial adaptors have come to be the safest solutions for quick transfer for drugs between vials. The demand for these vial adaptors is also expected to shoot up as they are exceptionally cost-effective and come with a reduced the risk of needlestick injuries. The growing prevalence of infectious diseases, widening pool of geriatrics, and increasing safety concerns have all triggered a demand for vial adaptors for reconstitution drugs. According to the research report, the global vial adaptors for reconstitution drug market was valued at US$780 mn in 2015 and is expected to reach US$1.3 bn by the end of 2024. Between the forecast years of 2016 and 2024, the global market is expected to progress at a CAGR of 7.5%.
Autoimmune Diseases to Drive Global Vial Adaptors for Reconstitution Drug Market
On the basis of therapeutic area, the vial adaptors for reconstitution drug market has been segmented into autoimmune diseases, infectious diseases, metabolic conditions, reproductive health and others. Currently, the infectious diseases segment holds a major share in the global vial adaptors for reconstitution drug therapeutic area segment. However, the autoimmune diseases segment is expected to show robust growth rate in the coming years. As of 2015, it was the second largest segment in the overall market in terms of revenue. The American Autoimmune Related Diseases Association (AARDA) states that more than 50 million individuals are affected by autoimmune disorders in the U.S. every year. This is expected to drive the autoimmune diseases segment in the coming years.
This exhaustive report includes a 360° view of the Vial Adaptors for Reconstitution Drug Market. Browse through this 155-page report to know what factors will shape the market during the period 2016-2024
North America to Remain the Leading Regional Market during Forecast Period
In terms of geography, the global market is segmented into North America, Europe, Asia Pacific, and Rest of the World. Out of these regional markets, North America remained dominant in the global vial adaptors for reconstitution drug market in 2015. Europe followed this lead closely. The high incidence of autoimmune diseases, rising technological advancements, and growing demand for needle-free products likely to support the growth of the vial adaptors for reconstitution drug market in North America. On the other hand, the demand in Europe will be fueled by increasing advancements in healthcare technology amidst rising safety concerns.
Analysts estimate that Asia Pacific is also likely to be a lucrative market for the vial adaptors for reconstitution drugs during the forecast period. The growing adoption of technology, high prevalence of autoimmune diseases such as diabetes, and increasing adoption of technology are all expected to make a significant contribution to the soaring vial adaptors for reconstitution drug market in Asia Pacific. This regional market will also be propelled by the swelling pool of geriatrics, who are prone to various medical conditions and a vast pool of unmet medical needs. The strengthening economies of Asia Pacific and improving access to healthcare in the region are also likely to augment the demand for vial adaptors for reconstitution drugs.
Global Vial Adaptors for Reconstitution Drug Market: Key Players
The key players operating in the global vial adaptors for reconstitution drug market are Baxter International Inc., Becton, Dickinson and Company, Cardinal Health, Inc., Sensile Medical AG, Unilife Corporation and West Pharmaceutical Services, Inc. The market is largely consolidated as major players hold a dominating share.
Request a brochure of this report to know what opportunities will emerge in the rapidly evolving Vial Adaptors for Reconstitution Drug Market during 2016- 2024
Transparency Market Research (TMR) is a market intelligence company, providing global business information reports and services. Our exclusive blend of quantitative forecasting and trends analysis provides forward-looking insight for thousands of decision makers. TMR’s experienced team of analysts, researchers, and consultants, use proprietary data sources and various tools and techniques to gather, and analyze information. Our business offerings represent the latest and the most reliable information indispensable for businesses to sustain a competitive edge.
Each TMR syndicated research report covers a different sector – such as pharmaceuticals, chemicals, energy, food & beverages, semiconductors, med-devices, consumer goods and technology. These reports provide in-depth analysis and deep segmentation to possible micro levels. With wider scope and stratified research methodology, TMR’s syndicated reports strive to provide clients to serve their overall research requirement.
US Office Contact
90 State Street, Suite 700
Albany, NY 12207
USA – Canada Toll Free: 866-552-3453